Boston Scientific Corp (NYSE: BSX) is 6.94% higher on its value in year-to-date trading and has touched a low of $65.52 and a high of $107.17 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The BSX stock was last observed hovering at around $94.13 in the last trading session, with the day’s gains setting it 1.39%.
Currently trading at $95.52, the stock is -7.21% and -4.55% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 11.91 million and changing 1.48% at the moment leaves the stock 10.39% off its SMA200. BSX registered 40.84% gain for a year compared to 6-month gain of 17.06%.
The stock witnessed a -9.24% loss in the last 1 month and extending the period to 3 months gives it a 5.51%, and is -7.81% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.21% over the week and 2.39% over the month.
Boston Scientific Corp (BSX) has around 53000 employees, a market worth around $140.97B and $16.75B in sales. Current P/E ratio is 76.57 and Fwd P/E is 29.27. Profit margin for the company is 11.07%. Distance from 52-week low is 45.79% and -10.87% from its 52-week high. The company has generated returns on investments over the last 12 months (5.95%).
with sales reaching $4.57B over the same period.The EPS is expected to grow by 13.93% this year, but quarterly earnings will post 14.32% year-over-year. Quarterly sales are estimated to grow 18.49% in year-over-year returns.
Boston Scientific Corp (BSX) Top Institutional Holders
The shares outstanding are 1.47B, and float is at 1.47B with Short Float at 0.78%.
The top institutional shareholder in the company is FMR LLC with over 141.46 million shares valued at $10.89 billion. The investor’s holdings represent 9.6192% of the BSX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 129.87 million shares valued at $10.0 billion to account for 8.8444 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 126.42 million shares representing 8.6093% and valued at over $9.74 billion, while STATE STREET CORP holds 4.1791 of the shares totaling 61.46 million with a market value of $4.73 billion.
Boston Scientific Corp (BSX) Insider Activity
The most recent transaction is an insider sale by Woodworth Emily, the company’s SVP, Global Controller and CAO. SEC filings show that Woodworth Emily sold 7,149 shares of the company’s common stock on Mar 03 ’25 at a price of $104.97 per share for a total of $0.75 million. Following the sale, the insider now owns 914.0 shares.
Boston Scientific Corp disclosed in a document filed with the SEC on Mar 04 ’25 that Woodworth Emily (SVP, Global Controller and CAO) sold a total of 482 shares of the company’s common stock. The trade occurred on Mar 04 ’25 and was made at $104.63 per share for $50432.0. Following the transaction, the insider now directly holds 432.0 shares of the BSX stock.
Still, SEC filings show that on Feb 28 ’25, Woodworth Emily (SVP, Global Controller and CAO) disposed off 9,887 shares at an average price of $101.13 for $1.0 million. The insider now directly holds 1,632 shares of Boston Scientific Corp (BSX).
